dostarlimab
gsk
[]
 yes, short f/u, but please note that data are mounting to suggest that io benefits are durable. relapse after initial response to io is uncommon.
he for she. GI Oncologist@Milwaukee, alum of #AIIMS (New Delhi), #NIH and #MayoClinic. Focus- #CRC, #UGI cancers, biliary cancer